Burkhard Jansen
Chief Tech/Sci/R&D Officer chez DERMTECH, INC.
Postes actifs de Burkhard Jansen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 03/09/2019 | - |
Historique de carrière de Burkhard Jansen
Anciens postes connus de Burkhard Jansen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
DermTech Operations, Inc.
 DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 01/01/2017 | 01/08/2019 |
| Corporate Officer/Principal | 01/10/2015 | 01/01/2017 | |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Chief Executive Officer | 01/01/2005 | - |
| Founder | 01/02/2010 | - | |
| President | 01/01/2005 | - |
Formation de Burkhard Jansen
| University of Graz | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Autriche | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DERMTECH, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- Burkhard Jansen
- Expérience
